Table 4 Differences in access to chemotherapy for surgical patients with pathologic stage III and IV, by Race/Ethnicity
From: Exploring the complexity and spectrum of racial/ethnic disparities in colon cancer management
| Â | Domain 5: Utilization of Chemotherapy | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Race/Ethnicity | aOR (Recommended) | p -value | aOR (Administered) | p -value | aOR (Omitted) | p -value | aOR (Too Sick/Died) | p -value | aOR (Delay > 90 days) | p -value |
White | 1.00 | (ref) | 1.00 | (ref) | 1.00 | (ref) | 1.00 | (ref) | 1.00 | (ref) |
Black | 1.00 (0.95–1.05) | 0.98 | 0.92 (0.86–0.99) | 0.03 | 1.12 (1.05–1.19) |  < 0.01 | 1.12 (1.00–1.25) | 0.05 | 1.24 (1.12–1.36) |  < 0.01 |
Hispanic/Spanish | 0.99 (0.92–1.06) | 0.70 | 1.32 (1.18–1.47) |  < 0.01 | 0.79 (0.72–0.87) |  < 0.01 | 1.13 (0.94- 1.35) | 0.19 | 1.14 (0.99–1.30) | 0.06 |
Southeast Asian | 1.45 (1.20–1.76) |  < 0.01 | 1.12 (0.89–1.41) | 0.32 | 0.84 (0.68–1.03) | 0.09 | 0.70 (0.47–1.04) | 0.08 | 1.17 (0.87–1.56) | 0.30 |
East Asian | 1.35 (1.16–1.58) |  < 0.01 | 0.97 (0.81–1.17) | 0.78 | 0.99 (0.83–1.16) | 0.87 | 0.85 (0.63–1.16) | 0.31 | 0.76 (0.56–1.03) | 0.08 |
South Asian | 1.00 (0.74–1.35) | 0.98 | 0.91 (0.62–1.33) | 0.62 | 1.10 (0.78–1.55) | 0.59 | 0.90 (0.47–1.73) | 0.76 | 0.85 (0.47–1.54) | 0.60 |
AIAE | 1.08 (0.81–1.45) | 0.61 | 0.89 (0.62–1.29) | 0.55 | 1.06 (0.76–1.49) | 0.74 | 0.88 (0.47–1.63) | 0.69 | 1.11 (0.65–1.91) | 0.70 |
NHOPI | 1.73 (1.04–2.76) | 0.03 | 1.08 (0.63–1.86) | 0.78 | 0.77 (0.46–1.29) | 0.33 | 0.22 (0.06–0.80) | 0.02 | 2.18 (1.26–3.75) | 0.01 |